Does DACTINOMYCIN Cause Rhabdomyosarcoma recurrent? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Rhabdomyosarcoma recurrent have been filed in association with DACTINOMYCIN (DACTINOMYCIN). This represents 0.4% of all adverse event reports for DACTINOMYCIN.
12
Reports of Rhabdomyosarcoma recurrent with DACTINOMYCIN
0.4%
of all DACTINOMYCIN reports
3
Deaths
0
Hospitalizations
How Dangerous Is Rhabdomyosarcoma recurrent From DACTINOMYCIN?
Of the 12 reports, 3 (25.0%) resulted in death.
Is Rhabdomyosarcoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACTINOMYCIN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does DACTINOMYCIN Cause?
Off label use (391)
Febrile neutropenia (226)
Neutropenia (205)
Product use in unapproved indication (203)
Drug ineffective (181)
Disease progression (151)
Vomiting (119)
Anaemia (109)
Thrombocytopenia (106)
Malignant neoplasm progression (103)
What Other Drugs Cause Rhabdomyosarcoma recurrent?
CYCLOPHOSPHAMIDE (19)
IFOSFAMIDE (19)
VINCRISTINE (18)
ETOPOSIDE (17)
DOXORUBICIN (14)
CARBOPLATIN (12)
IRINOTECAN (12)
TOPOTECAN (10)
IDARUBICIN (9)
TROFOSFAMIDE (9)
Which DACTINOMYCIN Alternatives Have Lower Rhabdomyosarcoma recurrent Risk?
DACTINOMYCIN vs DALBAVANCIN
DACTINOMYCIN vs DALFAMPRIDINE
DACTINOMYCIN vs DALTEPARIN
DACTINOMYCIN vs DAMOCTOCOG ALFA PEGOL
DACTINOMYCIN vs DANAPAROID